Active surveillance of serious adverse events following transfusion of COVID‐19 convalescent plasma

Background The reported incidence of adverse reactions following Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) transfusion has generally been lower than expected based on the inciden…

Read the full article here

Related Articles